Sunbird Bio

Cambridge, MA · Founded 2020 · Privately Held (backing)

Developer of a diagnostics platform designed to provide fast and accurate results in molecular diagnostics. Sunbird Bio is based in Cambridge, MA and was founded in 2020. Its last reported valuation was $16 million in Nov 2022. It has raised $27.3 million across 1 recorded round; the latest was a $23.2 million early-stage round in Apr 2023.

Last reported valuation
$16.0M
Oct 2026
Priced at
—
Total raised
$27.3M
Last round
Early Stage VC
Apr 2023
How much has Sunbird Bio raised?
$27.3Macross 1 recorded rounds · Apr 2023 – Apr 2023

Most recently, Sunbird Bio raised $23.2M in its Early Stage VC (Apr 2023).

Private Market View
More of Sunbird Bio with a free Private Market View account
  • ·The complete investor list: 11 names
  • ·Watch Sunbird Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Sunbird Bio round by round

1 rounds
Apr 2023Early Stage VC$23.2MSEC filing▮
10 investors participated

How much has Sunbird Bio raised?

Sunbird Bio has raised $27.3 million across 1 recorded round since 2023. The largest was a $23.2 million early-stage round in Apr 2023.

Sunbird Bio has filed 1 Form D with the SEC, most recently in May 2023 ($23.2 million sold to 10 investors).

Sunbird Bio investors

11 investors are on record for Sunbird Bio, including Alumni Ventures, EDBI, ARCH Venture Partners and S32. By type, the record holds 6 venture capital firms and 1 family office. The early-stage round in Apr 2023 drew 10 investors.

For fundraisers
Raising for a company like Sunbird Bio?

11 investors have backed Sunbird Bio.

See all 11 investors →

Frequently asked about Sunbird Bio

How much has Sunbird Bio raised?
Sunbird Bio has raised $27.3M in total across 1 recorded funding rounds.
When was Sunbird Bio's last funding round?
Sunbird Bio's most recent recorded round was Early Stage VC in Apr 2023, raising $23.2M.